英国甲状腺协会对英国格雷夫斯病管理的调查
Michael Atkinson1, Medha Agrawal2, Koteshwara Muralidhara3
1Swansea Bay University Health Board, Swansea, UK.
Clinical endocrinology
|May 9, 2025
概括
英国内分泌学家倾向于使用抗甲状腺药物治疗最初的格雷夫病,与全球趋势保持一致,但与NICE指南不同. TSH受体抗体越来越多地用于诊断和预后.
科学领域:
- 内分泌学 在内分泌学.
- 甲状腺学 甲状腺学
- 临床实践指南 临床实践指南
背景情况:
- 最近证据和格雷夫斯病治疗指南的变化造成了实践上的不确定性.
- 英国进行了一项调查,以评估目前对格雷夫斯病的管理策略.
研究的目的:
- 评估当前英国在格雷夫斯病管理方面的做法.
- 将英国管理与国内和国际趋势进行比较.
主要方法:
- 一项在线调查分发给了英国甲状腺协会和英国内分泌学会的成员.
- 该调查于2022年10月至2023年3月进行,针对的是内分泌学家.
主要成果:
- 95%的内分泌学家使用抗甲状腺药物 (ATD) 作为第一线治疗,主要是卡比马 (CMZ).
- TSH受体抗体 (TRAb) 广泛用于诊断 (95%) 和随访 (76%).
- 放射性 (RAI) 首选用于复发性疾病 (81%),常见的禁忌包括甲状腺眼病和怀孕.
结论:
- 在Graves病的诊断和预后中,TRAbs的使用正在增加.
- 抗甲状腺药仍然是首选的初始治疗方法,符合全球趋势,但不是NICE指南.
- 需要进一步的研究来了解影响当前治疗决策的因素.
相关概念视频
Myasthenia Gravis: Overview and Treatment
977
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
977
Synthesis and Regulation of Thyroid Hormones
3.9K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
3.9K
Inflammatory Bowel Disease IV: Pharmacological Management
80
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
80
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
241
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
241
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
101
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
101
Diabetes: Management and Pharmacotherapy
212
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
212


